Superantigens modulate bacterial density during staphylococcus aureus nasal colonization

Toxins

Volumn 7, Issue 5, 2015, Pages 1821-1836

  Xu, Stacey X ^a   Kasper, Katherine J ^a   Zeppa, Joseph J ^a   McCormick, John K ^a,b  

^a WESTERN UNIVERSITY   (Canada)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

Humanized mice; Nasal colonization; Staphylococcus aureus; Superantigen

Indexed keywords

HLA DR4 ANTIGEN; STAPHYLOCOCCUS ENTEROTOXIN A; STAPHYLOCOCCUS ENTEROTOXIN B; STAPHYLOCOCCUS TOXIN; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR; BACTERIAL ANTIGEN; ENTEROTOXIN; ENTEROTOXIN A, STAPHYLOCOCCAL; ENTEROTOXIN B, STAPHYLOCOCCAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL LOAD; BACTERIAL STRAIN; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; FLOW CYTOMETRY; HOST PATHOGEN INTERACTION; IMMUNE SYSTEM; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TRANSGENIC MOUSE; WESTERN BLOTTING; ANIMAL; IMMUNOLOGY; LIVER; LUNG; LYMPH NODE; MICROBIOLOGY; NOSE; T LYMPHOCYTE;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL LOAD; ENTEROTOXINS; FEMALE; HLA-DR4 ANTIGEN; LIVER; LUNG; LYMPH NODES; MALE; MICE, TRANSGENIC; NOSE; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS; T-LYMPHOCYTES;

EID: 84941212584     PISSN: None     EISSN: 20726651     Source Type: Journal    
DOI: 10.3390/toxins7051821     Document Type: Article

References (45)

1. Lowy, F.D. Staphylococcus aureus infections. N. Engl. J. Med. 1998, 339, 520-532.
2. Rehm, S.J.; Tice, A. Staphylococcus aureus: Methicillin-susceptible S. aureus to methicillin-resistant S. aureus and vancomycin-resistant S. aureus. Clin. Infect. Dis. 2010, 51, S176-S182.
3. Boucher, H.; Miller, L.G.; Razonable, R.R. Serious infections caused by methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 2010, 51, S183-S197.
4. Kluytmans, J.A.J.W.; Wertheim, H.F.L. Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections. Infection 2005, 33, 3-8.
5. Wertheim, H.F.L.; Melles, D.C.; Vos, M.C.; van Leeuwen, W.; van Belkum, A.; Verbrugh, H.A.; Nouwen, J.L. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect. Dis. 2005, 5, 751-762.
6. Ten Broeke-Smits, N.J.P.; Kummer, J.A.; Bleys, R.L.A.W.; Fluit, A.C.; Boel, C.H.E. Hair follicles as a niche of Staphylococcus aureus in the nose; is a more effective decolonisation strategy needed? J. Hosp. Infect. 2010, 76, 211-214.
7. Bibel, D.J.; Aly, R.; Shinefield, H.R.; Maibach, H.I.; Strauss, W.G. Importance of the keratinized epithelial cell in bacterial adherence. J. Investig. Dermatol. 1982, 79, 250-253.
8. Corrigan, R.M.; Miajlovic, H.; Foster, T.J. Surface proteins that promote adherence of Staphylococcus aureus to human desquamated nasal epithelial cells. BMC Microbiol. 2009, 9, 22, doi:10.1186/1471-2180-9-22.
9. Wertheim, H.F.; Vos, M.C.; Ott, A.; van Belkum, A.; Voss, A.; Kluytmans, J.A.; van Keulen, P.H.; Vandenbroucke-Grauls, C.M.; Meester, M.H.; Verbrugh, H.A. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 2004, 364, 703-705.
10. Kolata, J.; Bode, L.G.M.; Holtfreter, S.; Steil, L.; Kusch, H.; Holtfreter, B.; Albrecht, D.; Hecker, M.; Engelmann, S.; van Belkum, A.; et al. Distinctive patterns in the human antibody response to Staphylococcus aureus bacteremia in carriers and non-carriers. Proteomics 2011, 11, 3914-3927.
11. Brown, A.F.; Leech, J.M.; Rogers, T.R.; McLoughlin, R.M. Staphylococcus aureus colonization: Modulation of host immune response and impact on human vaccine design. Front. Immun. 2013, 4, doi:10.3389/fimmu.2013.00507.
12. Wertheim, H.F.; Walsh, E.; Choudhurry, R.; Melles, D.C.; Boelens, H.A.; Miajlovic, H.; Verbrugh, H.A.; Foster, T.; van Belkum, A. Key role for clumping factor B in Staphylococcus aureus nasal colonization of humans. PLoS Med. 2008, 5, e17, doi:10.1371/journal.pmed.0050017.
13. Weidenmaier, C.; Kokai-Kun, J.F.; Kristian, S.A.; Chanturiya, T.; Kalbacher, H.; Gross, M.; Nicholson, G.; Neumeister, B.; Mond, J.J.; Peschel, A. Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat. Med. 2004, 10, 243-245.
14. Roche, F.M.; Meehan, M.; Foster, T.J. The Staphylococcus aureus surface protein SasG and its homologues promote bacterial adherence to human desquamated nasal epithelial cells. Microbiol. 2003, 149, 2759-2767.
15. Clarke, S.R.; Andre, G.; Walsh, E.J.; Dufrêne, Y.F.; Foster, T.J.; Foster, S.J. Iron-regulated surface determinant protein A mediates adhesion of Staphylococcus aureus to human corneocyte envelope proteins. Infect. Immun. 2009, 77, 2408-2416.
16. Xu, S.X.; McCormick, J.K. Staphylococcal superantigens in colonization and disease. Front. Cell Infect. Microbiol. 2012, 2, doi:10.3389/fcimb.2012.00052.
17. Salgado-Pabón, W.; Breshears, L.; Spaulding, A.R.; Merriman, J.A.; Stach, C.S.; Horswill, A.R.; Peterson, M.L.; Schlievert, P.M. Superantigens are critical for Staphylococcus aureus infective endocarditis, sepsis, and acute kidney injury. mBio. 2013, 4, doi:10.1128/mBio.00494-13.
18. Jarraud, S.; Peyrat, M.A.; Lim, A.; Tristan, A.; Bes, M.; Mougel, C.; Etienne, J.; Vandenesch, F.; Bonneville, M.; Lina, G.; et al. A highly prevalent operon of enterotoxin gene, forms a putative nursery of superantigens in Staphylococcus aureus. J. Immunol. 2001, 166, 669-677.
19. Holtfreter, S.; Roschack, K.; Eichler, P.; Eske, K.; Holtfreter, B.; Kohler, C.; Engelmann, S.; Hecker, M.; Greinacher, A.; Bröker, B.M. Staphylococcus aureus carriers neutralize superantigens by antibodies specific for their colonizing strain: A potential explanation for their improved prognosis in severe sepsis. J. Infect. Dis. 2006, 193, 1275-1278.
20. Verkaik, N.J.; de Vogel, C.P.; Boelens, H.A.; Grumann, D.; Hoogenboezem, T.; Vink, C.; Hooijkaas, H.; Foster, T.J.; Verbrugh, H.A.; van Belkum, A.; et al. Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus. J. Infect. Dis. 2009, 199, 625-632.
21. Holtfreter, S.; Grumann, D.; Schmudde, M.; Nguyen, H.T.T.; Eichler, P.; Strommenger, B.; Kopron, K.; Kolata, J.; Giedrys-Kalemba, S.; Steinmetz, I.; et al. Clonal distribution of superantigen genes in clinical Staphylococcus aureus isolates. J. Clin. Microbiol. 2007, 45, 2669-2680.
22. Ferry, T.; Thomas, D.; Genestier, A.L.; Bes, M.; Lina, G.; Vandenesch, F.; Etienne, J. Comparative prevalence of superantigen genes in Staphylococcus aureus isolates causing sepsis with and without septic shock. Clin. Infect. Dis. 2005, 41, 771-777.
23. Burian, M.; Grumann, D.; Holtfreter, S.; Wolz, C.; Goerke, C.; Bröker, B.M. Expression of staphylococcal superantigens during nasal colonization is not sufficient to induce a systemic neutralizing antibody response in humans. Eur. J. Clin. Microbiol. Infect. Dis. 2012, 31, 251-256.
24. Narita, K.; Hu, D.L.; Tsuji, T.; Nakane, A. Intranasal immunization of mutant toxic shock syndrome toxin 1 elicits systemic and mucosal immune response against Staphylococcus aureus infection. FEMS Immunol. Med. Microbiol. 2008, 52, 389-396.
25. Krismer, B.; Peschel, A. Does Staphylococcus aureus nasal colonization involve biofilm formation? Future Microbiol. 2011, 6, 489-493.
26. Xu, S.X.; Gilmore, K.J.; Szabo, P.A.; Zeppa, J.J.; Baroja, M.L.; Haeryfar, S.M.M.; McCormick, J.K. Superantigens subvert the neutrophil response to promote abscess formation and enhance Staphylococcus aureus survival in vivo. Infect. Immun. 2014, 82, 3588-3598.
27. Gaskill, M.E.; Khan, S.A. Regulation of the enterotoxin B gene in Staphylococcus aureus. J. Biol. Chem. 1988, 263, 6276-6280.
28. Janeway, C.A., Jr. Selective elements for the V beta region of the T cell receptor: Mls and the bacterial toxic mitogens. Adv. Immunol. 1991, 50, 1-53.
29. Bohach, G.; Schlievert, P.M. Staphylococcal and streptococcal superantigens: An update. In Superantigens: Molecular Basis for the Role in Human Diseases; Fraser, J.D., Kotb, M., Eds.; ASM Press: Washington, DC, USA, 2007; pp. 21-36.
30. Holtfreter, S.; Nguyen, T.T.H.; Wertheim, H.; Steil, L.; Kusch, H.; Truong, Q.P.; Engelmann, S.; Hecker, M.; Völker, U.; van Belkum, A.; et al. Human immune proteome in experimental colonization with Staphylococcus aureus. Clin. Vaccine Immunol. 2009, 16, 1607-1614.
31. Spaulding, A.R.; Lin, Y.C.; Merriman, J.A.; Brosnahan, A.J.; Peterson, M.L.; Schlievert, P.M. Immunity to Staphylococcus aureus secreted proteins protects rabbits from serious illnesses. Vaccine 2012, 30, 5099-5109.
32. Lussow, A.R.; MacDonald, H.R. Differential effects of superantigen-induced "anergy" on priming and effector stages of a T cell-dependent antibody response. Eur. J. Immunol. 1994, 24, 445-449.
33. Lappin, E.; Ferguson, A.J. Gram-positive toxic shock syndromes. Lancet Infect. Dis. 2009, 9, 281-290.
34. Hofer, M.F.; Newell, K.; Duke, R.C.; Schlievert, P.M.; Freed, J.H.; Leung, D.Y. Differential effects of staphylococcal toxic shock syndrome toxin-1 on B cell apoptosis. Proc. Natl. Acad. Sci. USA 1996, 93, 5425-5430.
35. Llewelyn, M.; Cohen, J. Superantigens: Microbial agents that corrupt immunity. Lancet Infect. Dis. 2002, 2, 156-162.
36. McCormick, J.K.; Yarwood, J.M.; Schlievert, P.M. Toxic shock syndrome and bacterial superantigens: An update. Annu. Rev. Microbiol. 2001, 55, 77-104.
37. Ito, K.; Bian, H.J.; Molina, M.; Han, J.; Magram, J.; Saar, E.; Belunis, C.; Bolin, D.R.; Arceo, R.; Campbell, R.; et al. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis. J. Exp. Med. 1996, 183, 2635-2644.
38. Duthie, E.; Lorenz, L.L. Staphylococcal coagulase: Mode of action and antigenicity. Microbiology 1952, 6, 95-107.
39. Novick, R. Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus. Virology 1967, 33, 155-166.
40. Gill, S.R.; Fouts, D.E.; Archer, G.L.; Mongodin, E.F.; DeBoy, R.T.; Ravel, J.; Paulsen, I.T.; Kolonay, J.F.; Brinkac, L.; Beanan, M.; et al. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain and a biofilm-producing methicillin-resistant Staphylococcus epidermidis strain. J. Bacteriol. 2005, 187, 2426-2438.
41. Kiser, K.B.; Cantey-Kiser, J.M.; Lee, J.C. Development and characterization of a Staphylococcus aureus nasal colonization model in mice. Infect. Immun. 1999, 67, 5001-5006.
42. Fenner, L.; Widmer, A.F.; Dangel, M.; Frei, R. Distribution of spa types among meticillin-resistant Staphylococcus aureus isolates during a 6 year period at a low-prevalence university hospital. J. Med. Microbiol. 2008, 57, 612-616.
43. Yarwood, J.M.; McCormick, J.K.; Paustian, M.L.; Orwin, P.M.; Kapur, V.; Schlievert, P.M. Characterization and expression analysis of Staphylococcus aureus pathogenicity island 3. Implications for the evolution of staphylococcal pathogenicity islands. J. Biol. Chem. 2002, 277, 13138-13147.
44. Arnaud, M.; Chastanet, A.; Debarbouille, M. New vector for efficient allelic replacement in naturally nontransformable, low-GC-content, gram-positive bacteria. Appl. Environ. Microbiol. 2004, 70, 6887-6891.
45. Arsic, B.; Zhu, Y.; Heinrichs, D.E.; McGavin, M.J. Induction of the staphylococcal proteolytic cascade by antimicrobial fatty acids in community acquired methicillin resistant Staphylococcus aureus. PLoS One 2012, 7, e45952.